Share Price, page-18

Paul is absolutely with PYC and is leading the science (yes the team is about 20-25 people I think). Within the TKI they have access to equipment that is well out of the reach of a biotech the size of PYC and a lot of their cost is able to go through R&D rebates. The recent announcements about Paul shares 'should' have been expected as they are all part of the mechanisms approved last year and the changes to his title/role. The blandness of regulatory announcements often provide confusion and I have suggested they put an explanatory cover sheet next time - blame the company secretary if you want someone to blame but they are just doing their job.

Against my better judgement and in the absence of a CEO I have recently given the strongest feedback that I can to the Board that they need to lift the game on IR and I believe it is coming across the next 3 months starting with another quarterly in a few weeks. They are responding positively to the idea of investor meetings in Adel, Bris, Melb & Syd (so people better actually show up!) and they are looking into the idea of a webinar as well. All these things take time though and they seem very busy (and FWIW very positive but that could be wishful thinking on my part). I guess it is to be expected that their focus is internal and to large pharma because the stakes are so high but the reality is that the comms and leadership is insufficient to existing shareholders right now. I'm sure they have met their obligations in telling required news but it is certainly being undersold in terms of explaining the story so far and engaging existing shareholders. This stock went from 1.6c to 4.5c on the back of a milestone and a few professional presentations - it needs its story told properly to its existing shareholder base - obviously there are people out there that have begun to understand its potential and it's time that was refreshed for the existing shareholder base.

I am not comfortable posting here anymore cause I don't want to provide false impressions that I know things that I don't and I really hate getting directly involved but in this case I have communicated directly as there is no CEO speaking for the company and it pains me to see confusion among shareholders through lack of clear announcements explaining these type of announcements.

Over the past 6 months or so I have struggled Jekyl & Hyde style with HC - leaving and returning like an addict. Just like an addict I am going to try again to retreat from this space - I figure the only way I can do this is to block it at the router cause I can't trust myself. Good luck holders and maybe we will meet face to face one day - in the meantime, as I always try to be open and transparent - I am buying again under 3c.

It's an illness.